Massimo Di Maio

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 35

Top Topics

Epidermal Growth Factor Receptor

Systematic Review

Prostate Cancer

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Valentina Tuninetti, Eleonora Ghisoni, Sandro Pignata, Elisa Picardo, Francesco Raspagliesi, Claudia Andreetta, Elena Maldi, Grazia Artioli, Serafina Mammoliti, Lucia Zanchi, Angelica Sikokis, Nicoletta Biglia, Maria Concetta Fargnoli, Vincenzo Dario Mandato, Claudia Carella, Gennaro Cormio, Marco Marinaccio, Andrea Puppo, Biagio Paolini, Lucia Borsotti, Giulia Scotto, Margherita Turinetto, Dario Sangiolo, Massimo Di Maio, Giorgio Valabrega
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study. Cancers 15 (4) (2023)
Valentina Tuninetti, Luca Pace, Eleonora Ghisoni, Virginia Quarà, Francesca Arezzo, Andrea Palicelli, Vincenzo Dario Mandato, Elena Geuna, Gennaro Cormio, Nicoletta Biglia, Lucia Borsotti, Silvia Gallo, Annamaria Ferrero, Elena Jacomuzzi, Luca Fuso, Jeremy Oscar Smith Pezua Sanjinez, Andrea Puppo, Andrea Caglio, Chiara Rognone, Margherita Turinetto, Giulia Scotto, Massimo Di Maio, Giorgio Valabrega
Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience. Cancers 15 (14) (2023)
Anna Amela Valsecchi, Rossana Dionisio, Olimpia Panepinto, Jessica Paparo, Andrea Palicelli, Francesca Vignani, Massimo Di Maio
Frequency of Germline and Somatic BRCA1 and BRCA2 Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis. Cancers 15 (9) (2023)
Angioletta Lasagna, Antonella Brunello, Nicola Silvestris, Paolo Pedrazzoli, Massimo Di Maio, Saverio Cinieri
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical Oncology. Tumori (2023)
Irene Persano, Massimiliano Cani, Benedetta Del Rio, Giorgia Ferrari, Edoardo Garbo, Elena Parlagreco, Chiara Pisano, Valeria Cetoretta, Marco Donatello Delcuratolo, Ursula Maria Vogl, Alessandro Audisio, Cristina Cecchi, Gianmarco Leone, Valerio Maria Napoli, Valentina Bertaglia, Valentina Bianco, Enrica Capelletto, Carmen D'Amiano, Massimo Di Maio, Martina Gianetta, Silvia Novello, Francesco Passiglia, Giorgio Vittorio Scagliotti, Paolo Bironzo
Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center Experience. Biomedicines 11 (1) (2023)
Massimo Di Maio
The Value of Patient-Reported Outcomes in Single-Arm Cancer Trials. Cancer investigation (2023)
Paolo Bironzo, Massimiliano Cani, Francesca Jacobs, Valerio M Napoli, Angela Listì, Francesco Passiglia, Luisella Righi, Massimo Di Maio, Silvia Novello, Giorgio V Scagliotti
Real-world retrospective study of KRAS mutations in advanced nonsmall cell lung cancer in the era of immunotherapy. Cancer (2023)
Andrea Milani, Valentina Tuninetti, Sandro Pignata, Domenica Lorusso, Daniele Castaldo, Ugo De Giorgi, Antonella Savarese, Nicoletta Biglia, Giuseppa Scandurra, Giorgia Mangili, Massimo Di Maio, Margherita Turinetto, Marco Bellero, Serafina Mammoliti, Silvia Testa, Giulia Scotto, Andrea Purro, Grazia Artioli, Giorgio Valabrega
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society. Tumori (2023)
Irene Persano, Massimiliano Cani, Benedetta Del Rio, Giorgia Ferrari, Edoardo Garbo, Elena Parlagreco, Chiara Pisano, Valeria Cetoretta, Marco Donatello Delcuratolo, Ursula Maria Vogl, Alessandro Audisio, Cristina Cecchi, Gianmarco Leone, Valerio Maria Napoli, Valentina Bertaglia, Valentina Bianco, Enrica Capelletto, Carmen D'Amiano, Massimo Di Maio, Martina Gianetta, Silvia Novello, Francesco Passiglia, Giorgio Vittorio Scagliotti, Paolo Bironzo
Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center Experience. Biomedicines 11 (1) (2023)
Massimo Di Maio
Which patients should receive electronic patient-reported outcome measures in clinical practice? Cancer (2023)
Anna Amela Valsecchi, Rossana Dionisio, Olimpia Panepinto, Jessica Paparo, Andrea Palicelli, Francesca Vignani, Massimo Di Maio
Frequency of Germline and Somatic BRCA1 and BRCA2 Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis. Cancers 15 (9) (2023)
Valentina Tuninetti, Eleonora Ghisoni, Sandro Pignata, Elisa Picardo, Francesco Raspagliesi, Claudia Andreetta, Elena Maldi, Grazia Artioli, Serafina Mammoliti, Lucia Zanchi, Angelica Sikokis, Nicoletta Biglia, Maria Concetta Fargnoli, Vincenzo Dario Mandato, Claudia Carella, Gennaro Cormio, Marco Marinaccio, Andrea Puppo, Biagio Paolini, Lucia Borsotti, Giulia Scotto, Margherita Turinetto, Dario Sangiolo, Massimo Di Maio, Giorgio Valabrega
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study. Cancers 15 (4) (2023)
Massimo Di Maio
The Value of Patient-Reported Outcomes in Single-Arm Cancer Trials. Cancer investigation (2023)
Ursula Maria Vogl, Marcello Tucci, Tiziana Angusti, Antonella Parente, Rosario Francesco Di Stefano, Susanna Urban, Chiara Pisano, Alessandro Samuelly, Alessandro Audisio, Marco Audisio, Elena Parlagreco, Antonio Ungaro, Giorgio Vittorio Scagliotti, Massimo Di Maio, Consuelo Buttigliero
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis. Tumori (2022)
Anna Amela Valsecchi, Jessica Paparo, Valeria Pirro, Matteo Manfredi, Massimo Di Maio, Rossana Dionisio
Clinical value of offering multiple chemotherapy lines to a luminal-like metastatic breast cancer: A case report with eribulin. Tumori (2022)
Laura Marandino, Daniele Raggi, Andrea Necchi, Massimo Di Maio
Impact of Novel Hormonal Therapy on Cognitive Function: Essential to Measure, Difficult to Present. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (19) (2022)
Federica Morano, Alessandra Raimondi, Filippo Pagani, Sara Lonardi, Lisa Salvatore, Chiara Cremolini, Sabina Murgioni, Giovanni Randon, Federica Palermo, Lorenzo Antonuzzo, Nicoletta Pella, Patrizia Racca, Michele Prisciandaro, Monica Niger, Francesca Corti, Francesca Bergamo, Alberto Zaniboni, Margherita Ratti, Michele Palazzo, Celeste Cagnazzo, Maria Alessandra Calegari, Federica Marmorino, Iolanda Capone, Elena Conca, Adele Busico, Silvia Brich, Elena Tamborini, Federica Perrone, Massimo Di Maio, Massimo Milione, Maria Di Bartolomeo, Filippo de Braud, Filippo Pietrantonio
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O 6 -Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (14) (2022)
Annapaola Mariniello, Fabrizio Tabbò, Davide Indellicati, Martina Tesauro, Nicole Alessia Rezmives, Maria Lucia Reale, Angela Listì, Enrica Capelletto, Simona Carnio, Valentina Bertaglia, Caterina Mecca, Lorena Consito, Marco De Filippis, Maristella Bungaro, Chiara Paratore, Massimo Di Maio, Francesco Passiglia, Luisella Righi, Dario Sangiolo, Silvia Novello, Massimo Geuna, Paolo Bironzo
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer. Cells 11 (20) (2022)
Antonio Ungaro, Marcello Tucci, Alessandro Audisio, Lavinia Di Prima, Chiara Pisano, Ursula Maria Vogl, Marco Donatello Delcuratolo, Massimo Di Maio, Giorgio Vittorio Scagliotti, Consuelo Buttigliero
Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside. Cells 11 (5) (2022)
Annapaola Mariniello, Paolo Bironzo, Chiara Pisano, Marco De Filippis, Irene Persano, Emanuela Olmetto, Valeria Caramello, Adriana Boccuzzi, Enrica Capelletto, Francesco Passiglia, Massimo Di Maio, Silvia Novello
Descriptive Comparative Analysis of Patients With Cancer Referring to the Emergency Department of an Italian University Hospital Across the Severe Acute Respiratory Syndrome Coronavirus 2 Waves. JCO oncology practice 17 (12) (2021)
Marco Russano, Alessio Cortellini, Raffaele Giusti, Alessandro Russo, Federica Zoratto, Francesca Rastelli, Alain Gelibter, Rita Chiari, Olga Nigro, Michele De Tursi, Sergio Bracarda, Stefania Gori, Francesco Grossi, Melissa Bersanelli, Lorenzo Calvetti, Vincenzo Di Noia, Mario Scartozzi, Massimo Di Maio, Paolo Bossi, Alfredo Falcone, Fabrizio Citarella, Francesco Pantano, Corrado Ficorella, Marco Filetti, Vincenzo Adamo, Enzo Veltri, Federica Pergolesi, Mario Alberto Occhipinti, Linda Nicolardi, Alessandro Tuzi, Pietro Di Marino, Serena Macrini, Alessandro Inno, Michele Ghidini, Sebastiano Buti, Giuseppe Aprile, Eleonora Lai, Marco Audisio, Salvatore Intagliata, Riccardo Marconcini, Davide Brocco, Giampiero Porzio, Marta Piras, Erika Rijavec, Francesca Simionato, Clara Natoli, Marcello Tiseo, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation. Cancer immunology, immunotherapy : CII (2021)
Paolo Bironzo, Maria Lucia Reale, Tessa Sperone, Fabrizio Tabbò, Andrea Caglio, Angela Listì, Francesco Passiglia, Massimo Di Maio, Luisella Righi, Federico Bussolino, Giorgio Vittorio Scagliotti, Silvia Novello
Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations. Cancers 13 (10) (2021)
Giacomo Aimar, Chiara Paratore, Clizia Zichi, Donatella Marino, Elisa Sperti, Andrea Caglio, Teresa Gamba, Francesca De Vita, Massimo Di Maio
A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step? Exploration of targeted anti-tumor therapy 2 (5) (2021)
Silvia Riva, Laura Arenare, Massimo Di Maio, Fabio Efficace, Vincenzo Montesarchio, Luciano Frontini, Diana Giannarelli, Jane Bryce, Laura Del Campo, Francesco De Lorenzo, Elisabetta Iannelli, Francesca Traclò, Lara Gitto, Claudio Jommi, Concetta Maria Vaccaro, Daniela Barberio, Saverio Cinieri, Camillo Porta, Lucia Del Mastro, Vittorina Zagonel, Alessio Aligi Cogoni, Roberto Bordonaro, Anna Gimigliano, Maria Carmela Piccirillo, Lorenzo Guizzaro, Ciro Gallo, Francesco Perrone
Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system. BMJ open 11 (10) (2021)
Daniele Santini, Alfredo Berruti, Massimo Di Maio, Giuseppe Procopio, Sergio Bracarda, Toni Ibrahim, Francesco Bertoldo
Bone health management in the continuum of prostate cancer disease: a review of the evidence with an expert panel opinion. ESMO open 5 (2) (2021)
Serena Di Cosimo, Barbara Tagliaferri, Daniele Generali, Fabiola Giudici, Francesco Agustoni, Antonio Bernardo, Karen Borgonovo, Gabriella Farina, Giovanna Luchena, Andrea Luciani, Franco Nolè, Laura Palmeri, Filippo Pietrantonio, Guido Poggi, Paolo Andrea Zucali, Emanuela Balletti, Giovanna Catania, Ottavia Bernocchi, Federica D'Antonio, Monica Giordano, Francesco Grossi, Angioletta Lasagna, Nicla La Verde, Mariangela Manzoni, Benedetta Montagna, Angelo Olgiati, Alessandra Raimondi, Irene Rampinelli, Elena Verri, Alberto Zaniboni, Massimo Di Maio, Giordano Beretta, Marco Danova
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study. Cancers 13 (6) (2021)
Edoardo Lenci, Luca Cantini, Federica Pecci, Valeria Cognigni, Veronica Agostinelli, Giulia Mentrasti, Alessio Lupi, Nicoletta Ranallo, Francesco Paoloni, Silvia Rinaldi, Linda Nicolardi, Andrea Caglio, Sophie Aerts, Alessio Cortellini, Corrado Ficorella, Rita Chiari, Massimo Di Maio, Anne-Marie C Dingemans, Joachim G J V Aerts, Rossana Berardi
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab. Journal of clinical medicine 10 (5) (2021)
Sara Pusceddu, Claudio Vernieri, Massimo Di Maio, Natalie Prinzi, Martina Torchio, Francesca Corti, Jorgelina Coppa, Roberto Buzzoni, Maria Di Bartolomeo, Massimo Milione, Benjamin Regnault, Xuan-Mai Truong Thanh, Vincenzo Mazzaferro, Filippo de Braud
Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET Study. Cancers 14 (1) (2021)
Alessandra Raimondi, Federica Palermo, Michele Prisciandaro, Massimo Aglietta, Lorenzo Antonuzzo, Giuseppe Aprile, Rossana Berardi, Giovanni G Cardellino, Giovanni De Manzoni, Ferdinando De Vita, Massimo Di Maio, Lorenzo Fornaro, Giovanni L Frassineti, Cristina Granetto, Francesco Iachetta, Sara Lonardi, Roberto Murialdo, Elena Ongaro, Francesca Pucci, Margherita Ratti, Nicola Silvestris, Valeria Smiroldo, Andrea Spallanzani, Antonia Strippoli, Stefano Tamberi, Emiliano Tamburini, Alberto Zaniboni, Maria Di Bartolomeo, Chiara Cremolini, Carlo Sposito, Vincenzo Mazzaferro, Filippo Pietrantonio
TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study. Cancers 13 (11) (2021)
Laura Marandino, Francesca Vignani, Consuelo Buttigliero, Teresa Gamba, Andrea Necchi, Marcello Tucci, Massimo Di Maio
Evaluation of Cognitive Function in Trials Testing New-Generation Hormonal Therapy in Patients with Prostate Cancer: A Systematic Review. Cancers 12 (9) (2020)
Valentina Tuninetti, Marilena Di Napoli, Eleonora Ghisoni, Furio Maggiorotto, Manuela Robella, Giulia Scotto, Gaia Giannone, Margherita Turinetto, Dimitris Siatis, Riccardo Ponzone, Marco Vaira, Michele De Simone, Cono Scaffa, Sandro Pignata, Stefano Greggi, Massimo Di Maio, Giorgio Valabrega
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience. Cancers 12 (8) (2020)
Emmanuele De Luca, Donatella Marino, Massimo Di Maio
Ramucirumab, A Second-Line Option For Patients With Hepatocellular Carcinoma: A Review Of The Evidence. Cancer management and research 12 (2020)
Francesco Facchinetti, Massimo Di Maio, Marcello Tiseo
Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials. Cancers 12 (9) (2020)
Maria Vittoria Dieci, Francesco Massari, Raffaele Giusti, Alessandro Inno, Giuseppe Lombardi, Laura Noto, Antonio Passaro, Filippo Pietrantonio, Francesca Spada, Monica Valente, Massimo Di Maio, Valter Torri
Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM). ESMO open 3 (6) (2018)
Clizia Zichi, Marcello Tucci, Gianmarco Leone, Consuelo Buttigliero, Francesca Vignani, Daniele Pignataro, Giorgio V Scagliotti, Massimo Di Maio
Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives. BioMed research international 2017 (2017)